A New Consortium on Sickle Cell - FDA Today
This news that Reagan-Udall Foundation for the FDA and the ASH Research Collaborative have established a new Real-World-Evidence Consortium for Sickle Cell Disease which aims to "develop consensus recommendations on clinical outcomes important to treating people with SCD and apply those standards to real-world data sets."